Latham & Watkins represented Terns Pharmaceuticals in the offering, while Davis Polk & Wardwell represented the underwriters.Terns Pharmaceuticals, Inc. (Nasdaq: TERN) has agreed to sell, by way…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
